Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Avatar Builder | Contact Info | Update Email | Update Password | Leaderboards | Manage Favourite | Reputation | Reputation History | Subscriptions | Payment Info | Invoices | Favourites

Bullboard Post History

by Dachs1

Order by:

V.SBM	First Berlin updated the SBM equity report. > Target 0.98$ http://de.slideshare.net/MomentumPR/first-berlin-equity-research-sbmtsxv March 9, 2016
V.SBM	First Berlin updated the SBM equity report. > Target 0.98$ http://de.slideshare.net/MomentumPR/first-berlin-equity-research-sbmtsxv March 9, 2016
V.SBM	TF Chem Trophées de l'Innovation sucres https://www.youtube.com/watch?v=xKzQNEQ_570 March 7, 2016
V.SBM	RE:Sirona's subsidary planning 2016 expansion thank you - nice finding: "After six years of research focused on the... March 7, 2016
V.SBM	RE:value of the technology platform? Dachs1 wrote: The big question is not what the Compound (SBM-TFC-1067; SBM... March 2, 2016
V.SBM	value of the technology platform? The big question is not what the Compound (SBM-TFC-1067; SBM-TFC-837, etc... February 29, 2016
V.SBM	RE:RE:Allergan? The SGLT2 (RoW) would also suit to Pfizer/Allegan. February 26, 2016
V.SBM	Allergan? Read the investor presentation. page 29. Is this a hint? -> Merger or... February 26, 2016
V.SBM	RE:RE:RE:RE:2nd Qtr ends April 30/16 this is an investor presentation. Q2 means April - June. February 23, 2016
V.SBM	RE:RE:2nd Qtr ends April 30/16 It could be also P&G. They have some grow "problems" in China -... February 23, 2016
V.SBM	RE:Bausch + Lomb / Obagi / India Over the next couple of years, our focus would be to consistently expand... February 22, 2016
V.SBM	Bausch + Lomb / Obagi / India Bausch + Lomb launches Obagis blockbuster products in India for... February 22, 2016
V.SBM	RE:Biotech-Roundup: Sirona Biochem, Paion, Atossa Genetics, Bio google translater German -> English: After a streaky race of the year... February 20, 2016
V.SBM	Biotech-Roundup: Sirona Biochem, Paion, Atossa Genetics, Bio http://www.finanznachrichten.de/nachrichten-2016-02/36510753-biotech-roundup... February 20, 2016
V.SBM	SBM investor video German SBM investor video German: https://t.co/L2FFHX42ZY via @YouTube February 19, 2016
V.SBM	news within the next 4 month? Skin lightening SBM-TFC-1067? Skin lightening SBM-TFC-849? Diabetes SBM-TFC... February 18, 2016
V.SBM	RE:RE:RE:RE:RE:Atilla Interview thank you! here is the link: http://smallcapinvestor.de/category/video-2... February 11, 2016
V.SBM	RE:Dr. Géraldine Deliencourt-Godefroy - brilliant :) Dr. Graldine Deliencourt-Godefroy is an award-winning synthetic chemist and... February 6, 2016
V.SBM	Dr. Géraldine Deliencourt-Godefroy - brilliant :) http://docplayer.net/12203525-Aagps-tm-anti-aging-glyco-peptides-enhancing... February 6, 2016

Featured News Links

Learn About a Mining Portfolio of More Than 250 Projects and Royalties Across North America

Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.

New electric industrial heat technology to reduce greenhouse gas emissions

Discover Options Trading Strategies to Minimize your Tax Burden

The Many Indications that the Gold and Silver Sector is on the Verge of a Multi-Year Super Cycle

Featured Company

Nextleaf Solutions Ltd C.OILS

Nextleaf Solutions Ltd. is a cannabis processor with a portfolio of federally regulated emerging consumer brands, market ... view more »